Alkem Looks To Biosimilars With Enzene’s Teriparatide In India

Rival To Eli Lilly’s Forteo Will Help Alkem Move Into Biosimilars

 
• By Dave Wallace

With the approval in India of its Enzene subsidiary’s version of teriparatide, Alkem is setting its sights on the biosimilars market.

India_Testing
Alkem’s Enzene has had its teriparatide approved in India • Source: Shutterstock

More from Biosimilars

More from Products